FTSE/Xinhua Fund (“the FXP Fund”) (NYSE:FXP), on behalf of all persons who purchased or otherwise acquired shares in the FXP Fund, an exchange-traded fund (“ETF”) offered by ProShares Trust (“ProShares”), pursuant or traceable to ProShares’ false and misleading Registration Statement, Prospectuses, and Statements of Additional Information issued in connection with the FXP Fund’s shares.
The FXP Fund is an inverse leveraged ETF that seeks investment returns that are two times the inverse performance of the FTSE/Xinhua China 25 Index. The investigation centers on the allegation that the registration statement filed by ProShares failed to adequately disclose that FXP shares should not be held more than a single trading day and were not an appropriate hedge against a decline in the performance of the index.
Those who invested are advised to contact Jeremy Lieberman at 888-476-6529 or 212-661-1100 or [email protected] Pomerantz has prosecuted securities fraud claims for 70 years, and is regarded as one of the country’s premier class action firms. The firm has offices in New York City, Chicago, Washington, D.C., Burlingame, CA. and Columbus, Ohio.
CONTACT: Pomerantz Haudek Block Grossman & Gross LLP Teresa Webb (888) 476.6529 (888) 4.POMLAW [email protected]